| Literature DB >> 31324291 |
Ali S Alqahtani1,2, Wael M Abdel-Mageed1,3, Abdelaaty A Shahat1,2,4, Mohammad K Parvez1, Mohammed S Al-Dosari1, Ajamaluddin Malik5, Maged S Abdel-Kader6, Mansour S Alsaid1.
Abstract
In traditional Arabian medicine, the Rhus tripartita plant (family Anacardiaceae) has been used to treat inflammatory conditions. Although Rhus extracts have been reported for their cardioprotective effects, information regarding their active principle compounds remains insufficient. The present investigation was aimed at determining the antioxidant chemical constituents of the methanolic extract of R. tripartita stem bark and evaluating their ability to ameliorate methylglyoxal-induced endothelial cell apoptosis. Ten flavonoid compounds (1-10) were isolated and identified using DPPH radical scavenging bioassay-guided chromatographic separation. A new proanthocyanidin (rhuspartin) (1) was isolated and identified as 3,5,13,14-flavantetrol-(4β→8)-catechin, using extensive spectroscopic data and high resolution-mass spectrometry. Among the compounds (1, 5, 7-10) tested for toxicity toward cultured endothelial cells (HUVECs), the non-cytotoxic compounds 1 and 7 evinced cytoprotective potential that reversed the methylglyoxal-induced apoptosis (by 62% and 64%, respectively) through downregulation of caspase 3/7.Entities:
Keywords: Cardiovascular complications; Endothelial dysfunction; Oxidative stress; Proanthocyanidin; Rhus tripartita
Mesh:
Substances:
Year: 2019 PMID: 31324291 PMCID: PMC9307047 DOI: 10.1016/j.jfda.2019.02.002
Source DB: PubMed Journal: J Food Drug Anal Impact factor: 6.157
Fig. 1Chemical structures of the isolated compounds (1–10); Glc: glucose, Rha: rhamnose.
1H (700 MHz) and 13C NMR (175 MHz) data (in DMSO-d) for compound 1.
| no. | 7 | |
|---|---|---|
|
| ||
|
| ||
| 2 | 79.9, CH | 5.21, brs |
| 3 | 70.7, CH | 4.35, m |
| 4 | 30.8, CH | 4.49, d (2.0) |
| 5 | 156.6, C | |
| 6 | 107.8, CH | 6.15, d (8.0) |
| 7 | 128.8, CH | 6.34, m |
| 8 | 102.3, CH | 6.33, d (8.0) |
| 9 | 153.9, C | |
| 10 | 112.7, C | |
| 11 | 130.9, C | |
| 12 | 113.0, CH | 6.69, s |
| 13 | 145.1, C | |
| 14 | 144.5, C | |
| 15 | 115.7, CH | 6.50, d (8.0) |
| 16 | 115.8, CH | 6.48, d (8.0) |
| OH-3 | 6.84, brs | |
| OH-5 | 8.63–9.24, s | |
| OH-13 | 8.63–9.24, s | |
| OH-14 | 8.63–9.24, s | |
|
| ||
| 2′ | 80.5, CH | 4.43, d (7.1) |
| 3′ | 66.4, CH | 3.74, m |
| 4′ | 27.9, CH2 | |
| 5′ | 155.1, C | |
| 6′ | 97.0, CH | 5.91, s |
| 7′ | 155.3, C | |
| 8′ | 104.4, C | |
| 9′ | 153.6, C | |
| 10′ | 99.5, C | |
| 11′ | 130.4, C | |
| 12′ | 114.4, CH | 6.64, s |
| 13′ | 144.5, C | |
| 14′ | 144.4, C | |
| 15′ | 115.5, CH | 6.71, d (8.0) |
| 16′ | 116.9, CH | 6.28, d (8.0) |
| OH-3′ | 4.92, d (4.2) | |
| OH-5′ | 8.63–9.24, s | |
| OH-7′ | 8.63–9.24, s | |
| OH-13 | 8.63–9.24, s | |
| OH-14 | 8.63–9.24, s | |
Fig. 2A) Selected COSY ( ) and HMBC (H C) correlations for compound 1. B) Attribution of the absolute configuration of compound (1) by comparing calculated CD spectra with experimental spectra.
Fig. 3MTT assay showing the dose-dependent anti-apoptotic/cytoprotective activity of R. tripartita derived compounds 1 (A) and 7 (B) against MGO-toxicity in cultured HUVEC cells. (C) Apoptosis assay showing inhibition of MGO-induced cellular caspase-3/7 activation by R. tripartita derived compounds 1 and 7 in cultured HUVEC cells.